Kefir significantly improved the body weight, energy expenditure and basal metabolic rate in nonalcoholic fatty liver disease by inhibiting the lipogenesis pathway in leptin receptor-deficient ob/ob mice45. This evidence concerns the gene LEPR and metabolic dysfunction-associated steatotic liver disease.